We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$382M
AUM Growth
+$14.6M
Cap. Flow
+$8.08M
Cap. Flow %
2.11%
Top 10 Hldgs %
45.36%
Holding
368
New
43
Increased
157
Reduced
67
Closed
14

Top Sells

Rank Stock Value
1
RWR icon
State Street SPDR Dow Jones REIT ETF
RWR
+$7.75M
2
VTRS icon
Viatris
VTRS
+$2.58M
3
TFX icon
Teleflex
TFX
+$2.08M
4
BEN icon
Franklin Resources
BEN
+$1.92M
5
PII icon
Polaris
PII
+$1.54M

Sector Composition

Rank Sector Weight
1 Financials 4.92%
2 Healthcare 4.54%
3 Industrials 4.07%
4 Consumer Discretionary 3.49%
5 Technology 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
276
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$22.1K 0.01%
+450
New +$21.2K
TGT icon
277
Target
TGT
$68B
$21.2K 0.01%
350
-11,675
-97% -$692K
NNN icon
278
NNN REIT
NNN
$8.99B
$20.8K 0.01%
604
+2
+0.3% +$67
IYR icon
279
iShares US Real Estate ETF
IYR
$4.57B
$20.3K 0.01%
300
+200
+200% +$13.3K
LTC
280
LTC Properties
LTC
$2.15B
$19.9K 0.01%
528
+3
+0.6% +$111
CBL
281
DELISTED
CBL& Associates Properties, Inc.
CBL
$19.3K 0.01%
1,088
+5
+0.5% +$87
SDRL
282
DELISTED
Seadrill Limited Common Stock
SDRL
$19K 0.01%
2
DLR icon
283
Digital Realty Trust
DLR
$71.7B
$18.9K 0.01%
357
+4
+1% +$208
DOC icon
284
Healthpeak Properties
DOC
$14.8B
$18.9K ﹤0.01%
534
+4
+0.8% +$138
TEVA icon
285
Teva Pharmaceuticals
TEVA
$41.2B
$18.5K ﹤0.01%
350
+150
+75% +$6.93K
AMRE
286
DELISTED
AMREIT INC NEW COM STK
AMRE
$18.1K ﹤0.01%
1,095
POT
287
DELISTED
Potash Corp Of Saskatchewan
POT
$18.1K ﹤0.01%
500
+250
+100% +$8.41K
IGIB icon
288
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$17.4K ﹤0.01%
+320
New +$17.4K
DHC
289
Diversified Healthcare Trust
DHC
$2.14B
$16.9K ﹤0.01%
759
+5
+0.7% +$109
SPAB icon
290
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.94B
$16.9K ﹤0.01%
590
+4
+0.7% +$114
BP icon
291
BP
BP
$107B
$16.8K ﹤0.01%
+428
New +$16.9K
VNO icon
292
Vornado Realty Trust
VNO
$7.38B
$16.8K ﹤0.01%
232
UN
293
DELISTED
Unilever NV New York Registry Shares
UN
$16.4K ﹤0.01%
400
+200
+100% +$7.78K
AEC
294
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
$16.2K ﹤0.01%
955
+5
+0.5% +$83
ELS icon
295
Equity Lifestyle Properties
ELS
$12.6B
$15.9K ﹤0.01%
782
+2
+0.3% +$39
PHG icon
296
Philips
PHG
$26.1B
$15.8K ﹤0.01%
+649
New +$15.9K
TECK icon
297
Teck Resources
TECK
$32.6B
$15.2K ﹤0.01%
700
+400
+133% +$9.28K
FFC
298
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$782M
$15.2K ﹤0.01%
+789
New +$14.6K
EPI icon
299
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$15.2K ﹤0.01%
800
VOD icon
300
Vodafone
VOD
$37.4B
$14.5K ﹤0.01%
+393
New +$15.2K

Similar funds

Capital Analysts LLC's Q1 2014 Portfolio in Review

As of Q1 2014, Capital Analysts LLC held 368 positions worth $382M, up 4% from $368M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Capital Analysts LLC's Q1 2014 filing shows 43 new, 157 increased, 67 reduced and 14 closed positions. Its largest new stake was Zoetis: 66,053 shares worth $1.91M. The largest sale was State Street SPDR Dow Jones REIT ETF, an estimated $7.75M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Industrials.

  • Capital Analysts LLC's largest Q1 2014 buy was Zoetis: 66,053 shares worth $1.91M.
  • Capital Analysts LLC added most to Vanguard Real Estate ETF in Q1 2014, an estimated $9.48M increase.
  • Capital Analysts LLC's biggest Q1 2014 reduction was Viatris, cutting an estimated $2.58M.
  • Capital Analysts LLC fully exited State Street SPDR Dow Jones REIT ETF in Q1 2014, selling an estimated $7.75M.
  • Capital Analysts LLC's ten largest holdings make up 45% of its $382M portfolio in Q1 2014.
  • Capital Analysts LLC opened 43 new positions and closed 14 in Q1 2014.
  • Capital Analysts LLC's portfolio value rose 4% quarter-over-quarter to $382M.

Based on Capital Analysts LLC's 13F filing for Q1 2014, filed 12 Nov 2014.